Outcomes | Number of studies | Number of participants | Pooled effect sizes | Heterogeneity | |||
---|---|---|---|---|---|---|---|
IG | CG | SMD | 95%CI | I2 | P | ||
CHAQ | 4 | 124 | 117 | -0.32 | (-0.83, 0.19) | 73.2% | 0.011 |
QoL | 3 | 81 | 79 | 0.27 | (-0.04, 0.58) | 29.4% | 0.243 |
EPM | 2 | 62 | 61 | -0.26 | (-0.62, 0.09) | 0 | 0.574 |
VO2peak | 3 | 81 | 79 | 0.21 | (-0.10, 0.52) | 17.5% | 0.297 |
6MWT | 2 | 70 | 65 | 0.29 | (-0.05, 0.62) | 0 | 0.741 |
HRmax | 2 | 39 | 33 | 0.77 | (-0.26, 1.80) | 77.5% | 0.035 |
Pain | 3 | 89 | 83 | -0.50 | (-0.90, -0.10) | 50.2% | 0.134 |